# Psychosis in a Complex Medical Landscape: Diagnostic Challenges Posed by Systemic Lupus Erythematosus, Antiphospholipid Syndrome, Breast Cancer, and Temporal Lobe Resection

**Authors:** Khaled Alharmoodi, Jeremy Chan, Samuel Towell, Mateen Durrani

PMC · DOI: 10.7759/cureus.87266 · Cureus · 2025-07-04

## TL;DR

This case study explores the diagnostic challenges of psychosis in a patient with multiple complex medical conditions.

## Contribution

The paper presents a unique case highlighting the difficulty of diagnosing psychiatric symptoms in the context of overlapping medical conditions.

## Key findings

- The patient's symptoms could not be conclusively attributed to a single cause despite extensive testing.
- A multidisciplinary approach was essential for managing the patient's complex condition.
- The case emphasizes the need for careful observation and collaboration among specialists.

## Abstract

This study aimed to highlight the complex diagnostic process in a patient presenting with a new onset of both psychiatric and neurological signs and symptoms in the context of a complex medical background. A 60-year-old woman presented with psychosis, paranoia, disorientation, and choreiform movements, with a medical history of systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), active breast cancer, and a recent temporal lobe resection. The differential diagnoses considered included various neuropsychiatric conditions, such as neuropsychiatric SLE, steroid-induced psychosis, chemotherapy-induced neurotoxicity, and paraneoplastic syndrome, as well as primary psychotic disorder. The case illustrates the often inconclusive nature of various investigations, including autoimmune blood panels, magnetic resonance imaging, and electroencephalography, all of which failed to yield a definitive diagnosis. It also underscores the need for a multidisciplinary approach involving psychiatric and medical specialists, alongside regular observation and input from other ward staff, to optimally manage patients with such complex presentations.

## Linked entities

- **Diseases:** systemic lupus erythematosus (MONDO:0007915), antiphospholipid syndrome (MONDO:0017278), breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** PRTN3 (proteinase 3) [NCBI Gene 5657] {aka ACPA, AGP7, C-ANCA, CANCA, MBN, MBT}, C3 (complement C3) [NCBI Gene 718] {aka AHUS5, ARMD9, ASP, C3a, C3b, CPAMD1}, APOH (apolipoprotein H) [NCBI Gene 350] {aka B2G1, B2GP1, BG}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}, BTG3 (BTG anti-proliferation factor 3) [NCBI Gene 10950] {aka ANA, ANA/BTG3, APRO4, TOB5, TOB55, TOFA}, MPO (myeloperoxidase) [NCBI Gene 4353]
- **Diseases:** brain metastases (MESH:D001932), delirium (MESH:D003693), NPSLE (MESH:D020945), neuropsychiatric episode (MESH:C580065), neuropsychiatric effects (MESH:D065606), infection (MESH:D007239), SLE (MESH:D008180), Psychosis (MESH:D011618), cancer (MESH:D009369), inflammatory (MESH:D007249), insomnia (MESH:D007319), paranoia (MESH:D010259), disorganized thinking (MESH:D012562), brain (MESH:D001927), mood disturbances (MESH:D019964), autoimmune-related neurological symptoms (MESH:D020274), involuntary movements (MESH:D020820), choreiform movements (MESH:D002819), anxiety (MESH:D001007), Brain metastasis (MESH:D009362), hyperacusis (MESH:D012001), neuropsychiatric complications (MESH:D008107), neurotoxicity (MESH:D020258), PNS (MESH:D010257), hallucinations (MESH:D006212), cognitive decline (MESH:D003072), Breast Cancer (MESH:D001943), metastatic disease (MESH:D000092182), delusions (MESH:D063726), movement disorders (MESH:D009069), paranoid ideation (MESH:D001072), psychiatric side effects (MESH:D064420), movement symptoms (MESH:D012816), autoimmune (MESH:D001327), confusion (MESH:D003221), acute psychosis (MESH:D011605), APS (MESH:D016736), rigidity (MESH:D009127), agitation (MESH:D011595), anxiety disorder (MESH:D001008), Primary psychiatric disorder (MESH:D001523), delusional disorder (MESH:D012563), Neuropsychiatric (MESH:C000631768)
- **Chemicals:** Prednisolone (MESH:D011239), Steroid (MESH:D013256), hydroxychloroquine (MESH:D006886), T4 (MESH:D013974), olanzapine (MESH:D000077152), promethazine (MESH:D011398), Ca (MESH:D002118), lorazepam (MESH:D008140), Na (MESH:D012964), Mg (MESH:D008274)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12318353/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12318353/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC12318353/full.md

---
Source: https://tomesphere.com/paper/PMC12318353